Smartleaf Asset Management LLC Day One Biopharmaceuticals, Inc. Transaction History
Smartleaf Asset Management LLC
- $1.13 Trillion
- Q2 2025
A detailed history of Smartleaf Asset Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 5 shares of DAWN stock, worth $37. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 24
79.17%
Holding current value
$37
Previous $193,000
83.42%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DAWN
# of Institutions
188Shares Held
69.3MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$48.6 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$46.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$34.3 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$31 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$28.1 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $555M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...